Professor Jeffrey Kroon, PhD

Department of Experimental Vascular Medicine, Amsterdam University Medical Centers, Academic Medical Center, Amsterdam, The Netherlands

Jeffrey Kroon is an Associate Professor and Principal Investigator in the Department of Experimental Vascular Medicine at Amsterdam UMC, Netherlands, with a cross-appointment at the Laboratory of Angiogenesis and Vascular Metabolism, VIB-KU Leuven, Belgium. His research focuses on the pathophysiology of lipoprotein(a) [Lp(a)] and its role at the intersection of vascular metabolism and inflammation. Dr. Kroon specifically explores how the immunometabolic-inflammatory axis drives cardiovascular disease, contributing to the understanding of Lp(a)’s impact on vascular health.

Currently, Jeffrey and his team are investigating endothelial cell metabolic and immunomodulatory changes in response to atherogenic stimuli using 3D organ-on-chip systems, preclinical murine models and human studies. Their work spans translational, preclinical, and clinical research, aiming to bridge the gap between the lab and clinical practice.

Jeffrey’s work is funded by the Dutch Heart Foundation, The European Research Council, and The Netherlands Organization for Health Research and Development (ZonMW). His long-term goal is to strengthen endothelial function by selectively targeting intracellular metabolism and modulating the endothelium’s immunomodulatory roles to combat cardiovascular disease.

He has been serving on the boards of the Netherlands Vascular Biology Organization (NeVBO) and the Dutch Atherosclerosis Society (DAS) since 2021. Additionally, from 2025 onwards, he has been appointed as co-chair of the European Atherosclerosis Society (EAS) Congress Committee. This appointment underscores his significant contributions to the field of atherosclerosis research.